Recent developments with Mind Medicine Inc (MNMD) have led to the company’s beta value being reach -6.74 cents.

On Tuesday, Mind Medicine Inc (NASDAQ: MNMD) opened higher 2.19% from the last session, before settling in for the closing price of $8.68. Price fluctuations for MNMD have ranged from $2.41 to $12.22 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Company’s average yearly earnings per share was noted 35.25% at the time writing. With a float of $26.94 million, this company’s outstanding shares have now reached $41.10 million.

The extent of productivity of a business whose workforce counts for 57 workers is very important to gauge.

Mind Medicine Inc (MNMD) Insider and Institutional Ownership

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Mind Medicine Inc is 4.34%, while institutional ownership is 61.42%. The most recent insider transaction that took place on Mar 25 ’24, was worth 156,930. In this transaction Chief Executive Officer of this company sold 16,519 shares at a rate of $9.50, taking the stock ownership to the 580,202 shares. Before that another transaction happened on Mar 25 ’24, when Company’s Chief Medical Officer sold 6,578 for $9.50, making the entire transaction worth $62,491. This insider now owns 358,452 shares in total.

Mind Medicine Inc (MNMD) Latest Financial update

According to the Wall Street analysts, stocks earnings will be around 35.25% per share during the next fiscal year.

Mind Medicine Inc (NASDAQ: MNMD) Trading Performance Indicators

Check out the current performance indicators for Mind Medicine Inc (MNMD). In the past quarter, the stock posted a quick ratio of 3.22.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.45, a number that is poised to hit -0.53 in the next quarter and is forecasted to reach -1.50 in one year’s time.

Technical Analysis of Mind Medicine Inc (MNMD)

The latest stats from [Mind Medicine Inc, MNMD] show that its last 5-days average volume of 1.2 million was inferior to 1.93 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 17.29%. Additionally, its Average True Range was 0.89.

During the past 100 days, Mind Medicine Inc’s (MNMD) raw stochastic average was set at 63.98%, which indicates a significant increase from 15.40% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 71.52% in the past 14 days, which was lower than the 108.63% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $8.13, while its 200-day Moving Average is $4.75. Now, the first resistance to watch is $9.22. This is followed by the second major resistance level at $9.56. The third major resistance level sits at $9.78. If the price goes on to break the first support level at $8.66, it is likely to go to the next support level at $8.44. The third support level lies at $8.10 if the price breaches the second support level.

Mind Medicine Inc (NASDAQ: MNMD) Key Stats

There are currently 70,268K shares outstanding in the company with a market cap of 249.78 million. Presently, the company’s annual sales total 0 K according to its annual income of -95,730 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -23,860 K.